Literature DB >> 22714590

Dissecting the role of mTOR complexes in cellular senescence.

Manuel Serrano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714590      PMCID: PMC3383585          DOI: 10.4161/cc.21065

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

Review 2.  Cellular senescence in cancer and aging.

Authors:  Manuel Collado; Maria A Blasco; Manuel Serrano
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

3.  Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.

Authors:  Dudley W Lamming; Lan Ye; Pekka Katajisto; Marcus D Goncalves; Maki Saitoh; Deanna M Stevens; James G Davis; Adam B Salmon; Arlan Richardson; Rexford S Ahima; David A Guertin; David M Sabatini; Joseph A Baur
Journal:  Science       Date:  2012-03-30       Impact factor: 47.728

Review 4.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

5.  Suppression of replicative senescence by rapamycin in rodent embryonic cells.

Authors:  Tatiana V Pospelova; Olga V Leontieva; Tatiana V Bykova; Svetlana G Zubova; Valery A Pospelov; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

6.  Rapamycin decelerates cellular senescence.

Authors:  Zoya N Demidenko; Svetlana G Zubova; Elena I Bukreeva; Valery A Pospelov; Tatiana V Pospelova; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

7.  mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

Authors:  John T Cunningham; Joseph T Rodgers; Daniel H Arlow; Francisca Vazquez; Vamsi K Mootha; Pere Puigserver
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

8.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

Authors:  David E Harrison; Randy Strong; Zelton Dave Sharp; James F Nelson; Clinton M Astle; Kevin Flurkey; Nancy L Nadon; J Erby Wilkinson; Krystyna Frenkel; Christy S Carter; Marco Pahor; Martin A Javors; Elizabeth Fernandez; Richard A Miller
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

9.  Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.

Authors:  Colin Selman; Jennifer M A Tullet; Daniela Wieser; Elaine Irvine; Steven J Lingard; Agharul I Choudhury; Marc Claret; Hind Al-Qassab; Danielle Carmignac; Faruk Ramadani; Angela Woods; Iain C A Robinson; Eugene Schuster; Rachel L Batterham; Sara C Kozma; George Thomas; David Carling; Klaus Okkenhaug; Janet M Thornton; Linda Partridge; David Gems; Dominic J Withers
Journal:  Science       Date:  2009-10-02       Impact factor: 47.728

  9 in total
  26 in total

1.  Fasting levels of hepatic p-S6 are increased in old mice.

Authors:  Olga V Leontieva; Geraldine M Paszkiewicz; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 2.  Geroconversion: irreversible step to cellular senescence.

Authors:  Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 3.  mTOR Signaling from Cellular Senescence to Organismal Aging.

Authors:  Shaohua Xu; Ying Cai; Yuehua Wei
Journal:  Aging Dis       Date:  2013-12-05       Impact factor: 6.745

4.  MEK drives cyclin D1 hyperelevation during geroconversion.

Authors:  O V Leontieva; Z N Demidenko; M V Blagosklonny
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

5.  Identification of rictor as a novel substrate of Polo-like kinase 1.

Authors:  Tian Shao; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

7.  Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2015-09-15

8.  Rapamycin extends life- and health span because it slows aging.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2013-08       Impact factor: 5.682

9.  M(o)TOR of aging: MTOR as a universal molecular hypothalamus.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2013-07       Impact factor: 5.682

10.  CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2013-08-22       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.